Brief: Passage Bio To Present Updated Interim Data From Imagine-1 Study For Gm1 Gangliosidosis At 19Th Annual Worldsymposium™ 2023
Feb 15 (Reuters) - Passage Bio Inc PASG.O :
* PASSAGE BIO TO PRESENT UPDATED INTERIM DATA FROM IMAGINE-1
STUDY
FOR GM1 GANGLIOSIDOSIS AT 19TH ANNUAL WORLDSYMPOSIUM™ 2023
Source text for Eikon: ID:nGNX4MPnlk
Further company coverage: PASG.O
((Reuters.Briefs@thomsonreuters.com;;))